why choose us

First received: February 15, 2023

Clinical Trial: Prediction of Getting Peripheral Neuropathy in Patients Treated With Bortezomib?

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chemotherapy-induced Peripheral Neuropathy

Study Type: OBSERVATIONAL


Official Title: Neurofilament Light Chain as Biomarker for Bortezomib-induced Peripheral Neuropathy

Brief Summary: Investigation of which patients treated with bortezomib that have increased risk of developing peripheral neuropathy.

Read more